Announcements Trials
Browse Landscape

Phase

Phase 3 9Phase 4 5Phase 2 4Phase NA 1

Status

Completed 4Unknown 3Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 3NIH 1

Study Type

Interventional 4

Sponsor

Cancer Type

Thoracic 2Lymphoid 1CNS 1

Conditions

Small Cell Lung Carcinoma 1Pancoast Syndrome 1Neuroblastoma 1Lymphoma, T-Cell, Peripheral 1Lung Neoplasms 1

Interventions

Cyclophosphamide 741Cisplatin 688Gemcitabine 641Bevacizumab 616Carboplatin 605Paclitaxel 601Docetaxel 565Radiotherapy 536Fluorouracil 405Oxaliplatin 387Rituximab 369Doxorubicin 361Capecitabine 342Filgrastim 333Etoposide 330Dexamethasone 312Irinotecan 309pembrolizumab 282Leucovorin 274Cetuximab 268Cytarabine 242Erlotinib Hydrochloride 231Nivolumab 228Prednisone 227Trastuzumab 225Vincristine 221Bortezomib 221Methotrexate 207Pemetrexed 199fludarabine phosphate 195

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × Completed × Vindesine × Clear all
NCT00136565 2018-08-23

Study of Bortezomib Combined With ACVBP in Peripheral T-cell Lymphoma

Lymphoma Study Association

Phase 2 Completed
60 enrolled
Lymphoid

Lymphoma, T-Cell, Peripheral

NCT00128037 2016-09-22

Trial of Pre-operative Chemoradiotherapy Followed by Surgical Resection in Pancoast Tumors (JCOG 9806)

Japan Clinical Oncology Group

Phase 2 Completed
75 enrolled
Thoracic

Lung Neoplasms, Pancoast Syndrome

NCT00759824 2015-02-12

A Phase II Study of Doxorubicin, Cyclophosphamide and Vindesine With Valproic Acid in Patients With Refractory or Relapsing Small Cell Lung Cancer After Platinum Derivatives and Etoposide

European Lung Cancer Working Party

Phase 2 Completed
64 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT00017225 2013-08-02

Chemotherapy and Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Neuroblastoma

National Cancer Institute (NCI)

Phase 2 Completed
CNS

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡